
About this episode
Botulinum toxin and surgical intervention in children and adolescents with cerebral palsy: who, when and why do we treat?
Jane Valentine, Sue-Anne Davidson, Natasha Bear, Eve Blair, Roslyn Ward, Ashleigh Thornton , Katherine Stannage, Linda Watson, David Forbes, Catherine Elliott
- PMID: 31415723
- DOI: 10.1080/09638288.2019.1644381
Abstract
Introduction: This audit aimed to increase understanding of the long-term outcomes of evidence-based medical and surgical interventions to improve gross motor function in children and adolescents with Cerebral Palsy.
Methods: Retrospective audit of a birth cohort (2000-2009) attending a tertiary service in Western Australia.
Results: The cohort comprises 771 patients aged 8 to 17 years. Percentage of children receiving no Botulinum Toxin treatments in each Gross Motor Functional Classification System level was: I: 40%, II: 26%, III: 33%, IV: 28% and V: 46%. Of the total cohort, 53% of children received 4 or less Botulinum Toxin treatments and 3.7% received more than 20 treatments. Statistically significant difference in the rate of use of Botulinum Toxin pre and post-surgery (p < 0.001) was documented. Children levels IV and V had 5 times the odds of surgery compared to children levels I-III (Odds Ratio 5.2, 95% Confidence Interval 3.5 to 7.8, p < 0.001). For 578 (75%) of participants the last recorded level was the same as the first.
Conclusion: This audit documents medical intervention by age and Gross Motor Functional Classification System level in a large cohort of children with cerebral palsy over time and confirms stability of the level in the majority.IMPLICATIONS FOR REHABILITATIONThe information from this audit may be of use in discussions with families regarding the timing and use of Botulinum toxin and surgical intervention for motor function in children and adolescents with Cerebral Palsy.Long term use of Botulinum Toxin within an integrated evidence-based clinical program is not associated with loss of gross motor function in the long term as evidenced by the maintenance of Gross Motor Functional Classification System stability.
Keywords: Cerebral palsy; botulinum toxin; children; gross motor function classification; orthopedic surgery.
Get every episode summarized
Each time The ResearchWorks Podcast publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from The ResearchWorks Podcast

What are the barriers and facilitators to participation of people with down synd...
The ResearchWorks Podcast

Longitudinal decline in upper-limb range of motion in adults with cerebral palsy...
The ResearchWorks Podcast

Hip Displacement in Spastic Hemiplegia (Dr Jason Howard)
The ResearchWorks Podcast

A preview of EACD 2026 (Dr Hazel Killeen and Dr Rory O'Sullivan)
The ResearchWorks Podcast